Alliance calls on experts to join its new collaborative community, seeking to overcome regulatory and data challenges preventing the replacement and reduction of animal testing.

Aptamer Group, the developer of novel Optimer® binders to enable innovation in the life sciences industry, provides an update on the partnership with Unilever to deliver Optimer binders for cosmetic applications.

Biora Therapeutics, Inc. has shared positive topline results from its clinical trial of BT-600, an orally administered drug-device combination in development for the potential treatment of ulcerative colitis.

Optibrium has announced the publication of a paper demonstrating the successful application of the QuanSA method to accelerate the lead optimization of a complex macrocyclic natural product during agrochemical development.

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK from 18–19 November 2024.

Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program.

Four new anti-idiotypic antibodies and a new anti-MMAE antibody range support bioanalytical assay development for preclinical research and clinical trials.

Study published in Bone Marrow Transplantation uses real-world clinical data to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms.

Investment of more than 50 million USD to meet growing global demand for drug and hydrophilic coatings for medical devices and components.

Zapnometinib is now ready for clinical development in severe influenza, an area without approved therapies and with a rapidly evolving pandemic threat from bird flu virus H5N1.